Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tricia White"'
Publikováno v:
Journal of Science Policy & Governance. 19
Policy decisions should be informed by science, but legislators and their teams have limited capacity to connect with evidence-based resources and the expert community. By strengthening ties between science and policy, these two domains can be more r
Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma
Autor:
Tricia White, Edward A. Neuwelt, Kirsten Johansson, Laszlo Szidonya, Nancy D. Doolittle, Prakash Ambady, Jessica James, Caroline Jezierski, Jenny Firkins
Publikováno v:
Leukemialymphoma. 60(2)
Primary central nervous system lymphoma (PCNSL) is an extemely rare, CD20+ non-germinal center B cell lymphoma (diffuse large cell type) in a bed of T-cell rich tumor microenvironment. The prognost...
Autor:
Rose Marie Tyson, Tricia White, Edward A. Neuwelt, Cynthia Lacy, Morad Nasseri, Seymur Gahramanov, Rongwei Fu, Csanad Varallyay, Sakir H. Gultekin, Randy Woltjer, Joao Prola Netto
SUMMARY Aims: This retrospective study determined the survival of glioblastoma patients with or without pseudoprogression. Methods: A total of 68 patients were included. Overall survival was compared between patients showing pseudoprogression (in mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc2c750590d021ed913330b01dbdf7e
https://europepmc.org/articles/PMC4590772/
https://europepmc.org/articles/PMC4590772/
Autor:
Rose Marie Tyson, Morad Nasseri, Edward A. Neuwelt, Rochelle Fu, Randy Woltjer, Cynthia Lacy, Seymur Gahramanov, Joao Prola Netto, Leslie L. Muldoon, Sakir H. Gultekin, Tricia White
Publikováno v:
Journal of Clinical Oncology. 32:2010-2010
2010 Background: This retrospective IRB approved study determined the survival of GBM patients with or without pseudoprogression. Methods: Patients with histologically-proven newly diagnosed GBM at...
Autor:
Edward A. Neuwelt, Rose Marie Tyson, Morad Nasseri, Stephen Giles, Tricia White, Seymur Gahramanov, Joao Prola Netto, Rochelle Fu, Cynthia Lacy
Publikováno v:
Journal of Clinical Oncology. 31:e13001-e13001
e13001 Background: Radiation therapy with concomitant temozolomide (TMZ) followed by 6 months of adjuvant TMZ is standard of care in newly diagnosed glioblastoma multiforme (GBM). The 6-month time frame for adjuvant TMZ was chosen arbitrarily and the